Wheatley S
The Law School, University of Liverpool, UK.
Eur Hum Rights Law Rev. 2001;3:312-25.
As medical technology develops, new issues are raised as to how the use of this technology may comply or conflict with existing human rights standards and values. This article considers the application of human rights standards, and in particular the jurisprudence under Article 8 of the European Convention on Human Rights, to the trade in human body organs, the selection of the sex of prospective children, and human reproductive cloning. The current domestic law and regulatory framework is examined, as well as international regulation of this area by the Council of Europe Convention on Human Rights and Biomedicine. The author considers how the balance is to be struck between the ethical objections to many developments in biomedicine, and individual self-determination. It is suggested that, in order to be justified, any limitations on individual self-determination in the use of this new medical technology, should have a basis in the protection of human dignity.
随着医学技术的发展,出现了一些新问题,即这种技术的使用如何符合或违背现有人权标准和价值观。本文探讨人权标准的适用情况,尤其是《欧洲人权公约》第八条项下的判例法在人体器官交易、未来子女性别选择和人类生殖性克隆方面的适用。同时考察了现行国内法律和监管框架,以及欧洲委员会《人权与生物医学公约》对该领域的国际监管。作者思考了如何在对生物医学诸多发展的伦理反对意见与个人自主决定权之间达成平衡。文中指出,为了具有正当性,对个人使用这种新医疗技术的自主决定权的任何限制都应以保护人类尊严为依据。